TABLE 2

Comparison of 18F-DCFPyL Uptake

TissueCohortMinutes after injectionnSUVmaxP
Malignant lesionsFasting6015210.20.420
Nonfasting13110.5
Fasting12015212.50.391
Nonfasting13112.8
Submandibular gland*Fasting605016.20.017
Nonfasting4718.7
Fasting120
Nonfasting
LiverFasting60506.8<0.001
Nonfasting487.7
Fasting120506.9<0.001
Nonfasting487.9
SpleenFasting60485.60.035
Nonfasting476.4
Fasting120484.60.050
Nonfasting474.8
DuodenumFasting605011.40.013
Nonfasting4813.3
Fasting1205013.30.211
Nonfasting4814.6
Intestine (other)Fasting60384.30.116
Nonfasting384.9
Fasting120383.80.006
Nonfasting385.5
  • ↵* Activity in the right submandibular gland was measured at only the first postinjection time point, whereas activity in the other tissues was measured at both time points.

  • For malignant lesions, spleen, and intestine (other), SUVmax is median and P was obtained with Mann–Whitney U test; for submandibular gland, liver, and duodenum, SUVmax is mean and P was obtained with t test.